Bill Text: IL SB0173 | 2021-2022 | 102nd General Assembly | Introduced
Bill Title: Creates the Sickle Cell Prevention, Care, and Treatment Program Act. Requires the Department of Public Health to establish a grant program for the prevention, care, and treatment of sickle cell disease and for educational programs concerning the disease. Requires the Department to: (1) develop application criteria and standards of eligibility for groups or organizations that apply for funds under the program; and (2) make available grants to groups and organizations that meet the eligibility standards set by the Department. Provides that the highest priority for grants shall be given to established sickle cell disease community-based organizations, and priority shall be given to ensuring the establishment of sickle cell disease centers in underserved areas with a higher population of sickle cell disease patients. Requires the Department to determine the maximum amount available for each grant; determine policies for the expiration and renewal of grants; require that all grant funds be used for the purpose of prevention, care, and treatment of sickle cell disease or for educational programs concerning the disease; and develop a sickle cell disease educational outreach program that includes the dissemination of educational materials to specified persons and institutions. Permits the Department to contract with an entity to implement the outreach program. Requires the Department to adopt rules. Requires the Department to conduct a study to determine the prevalence, impact, and needs of individuals with sickle cell disease and the sickle cell trait in Illinois. Provides that implementation of the Act is subject to appropriation. Amends the State Finance Act. Creates the Sickle Cell Chronic Disease Fund.
Spectrum: Partisan Bill (Democrat 6-0)
Status: (Introduced - Dead) 2021-04-16 - Rule 3-9(a) / Re-referred to Assignments [SB0173 Detail]
Download: Illinois-2021-SB0173-Introduced.html
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
1 | AN ACT concerning public health.
| ||||||||||||||||||||||||||
2 | Be it enacted by the People of the State of Illinois,
| ||||||||||||||||||||||||||
3 | represented in the General Assembly:
| ||||||||||||||||||||||||||
4 | Section 1. Short title. This Act may be cited as the Sickle | ||||||||||||||||||||||||||
5 | Cell Prevention, Care, and Treatment Program Act.
| ||||||||||||||||||||||||||
6 | Section 5. Definitions. As used in this Act: | ||||||||||||||||||||||||||
7 | "Department" means the Department of Public Health. | ||||||||||||||||||||||||||
8 | "Program" means the Sickle Cell Prevention, Care, and | ||||||||||||||||||||||||||
9 | Treatment Program.
| ||||||||||||||||||||||||||
10 | Section 10. Sickle Cell Prevention, Care, and Treatment | ||||||||||||||||||||||||||
11 | Program. The Department shall establish a grant program for | ||||||||||||||||||||||||||
12 | the purpose of providing for the prevention, care, and | ||||||||||||||||||||||||||
13 | treatment of sickle cell disease and for educational programs | ||||||||||||||||||||||||||
14 | concerning the disease.
| ||||||||||||||||||||||||||
15 | Section 15. Grants; eligibility standards. | ||||||||||||||||||||||||||
16 | (a) The Department shall do the following: | ||||||||||||||||||||||||||
17 | (1)(A) Develop application criteria and standards of | ||||||||||||||||||||||||||
18 | eligibility for groups
or organizations that apply for | ||||||||||||||||||||||||||
19 | funds under the program. | ||||||||||||||||||||||||||
20 | (B) Make available grants to groups and organizations | ||||||||||||||||||||||||||
21 | that meet
the eligibility standards set by the Department. |
| |||||||
| |||||||
1 | However: | ||||||
2 | (i) the highest priority for grants shall be | ||||||
3 | accorded to
established sickle cell disease
| ||||||
4 | community-based organizations throughout Illinois; and | ||||||
5 | (ii) priority shall also be given to ensuring the
| ||||||
6 | establishment of sickle cell disease centers in | ||||||
7 | underserved
areas that have a higher population of | ||||||
8 | sickle cell disease
patients. | ||||||
9 | (2) Determine the maximum amount available for each | ||||||
10 | grant provided under subparagraph (B) of paragraph (1). | ||||||
11 | (3) Determine policies for the expiration and renewal | ||||||
12 | of grants provided under subparagraph (B) of paragraph | ||||||
13 | (1). | ||||||
14 | (4) Require that all grant funds be used for the | ||||||
15 | purpose of
prevention, care, and treatment of sickle cell | ||||||
16 | disease or
for educational programs concerning the | ||||||
17 | disease.
Grant funds shall be used for one or more of the | ||||||
18 | following purposes: | ||||||
19 | (A) Assisting in the development and expansion of | ||||||
20 | care for the
treatment of individuals with sickle cell | ||||||
21 | disease, particularly
for adults, including the | ||||||
22 | following types of care: | ||||||
23 | (i) Self-administered care. | ||||||
24 | (ii) Preventive care. | ||||||
25 | (iii) Home care. | ||||||
26 | (iv) Other evidence-based medical procedures |
| |||||||
| |||||||
1 | and
techniques designed to provide maximum control | ||||||
2 | over
sickling episodes typical of occurring to an | ||||||
3 | individual with
the disease. | ||||||
4 | (B) Increasing access to health care for | ||||||
5 | individuals with sickle cell disease. | ||||||
6 | (C) Establishing additional sickle cell disease | ||||||
7 | infusion centers. | ||||||
8 | (D) Increasing access to mental health resources | ||||||
9 | and pain management therapies for individuals with | ||||||
10 | sickle cell disease. | ||||||
11 | (E) Providing counseling to any individual, at no | ||||||
12 | cost, concerning sickle cell disease and the sickle | ||||||
13 | cell trait, and the characteristics, symptoms, and | ||||||
14 | treatment of the disease. | ||||||
15 | (i) The counseling described in this | ||||||
16 | subparagraph (E) may consist of any of the | ||||||
17 | following: | ||||||
18 | (I) Genetic counseling for an individual | ||||||
19 | who tests positive for the sickle cell trait. | ||||||
20 | (II) Psychosocial counseling for an | ||||||
21 | individual who tests positive for sickle cell | ||||||
22 | disease, including any of the following: | ||||||
23 | (aa) Social service counseling. | ||||||
24 | (bb) Psychological counseling. | ||||||
25 | (cc) Psychiatric counseling.
| ||||||
26 | (5) Develop a sickle cell disease educational
outreach |
| |||||||
| |||||||
1 | program that includes the dissemination of
educational | ||||||
2 | materials to the following concerning sickle cell
disease | ||||||
3 | and the sickle cell trait:
| ||||||
4 | (A) Medical residents. | ||||||
5 | (B) Immigrants. | ||||||
6 | (C) Schools and universities. | ||||||
7 | (6) Adopt any rules necessary to implement the | ||||||
8 | provisions of this Act. | ||||||
9 | (b) The Department may contract with an entity to
| ||||||
10 | implement the sickle cell disease educational outreach program
| ||||||
11 | described in paragraph (5) of subsection (a).
| ||||||
12 | Section 20. Sickle Cell Chronic Disease Fund. | ||||||
13 | (a) The Sickle Cell Chronic Disease Fund is
created as a | ||||||
14 | special fund in the State treasury for the purpose of carrying | ||||||
15 | out the provisions of this
Act and for no other
purpose. The | ||||||
16 | Fund shall be administered by the Department.
| ||||||
17 | (b) The Fund shall consist of: | ||||||
18 | (1) Any moneys appropriated to the Department for the | ||||||
19 | Sickle Cell Prevention, Care, and Treatment Program. | ||||||
20 | (2) Gifts, bequests, and other sources of funding. | ||||||
21 | (3) All interest earned on moneys in the Fund.
| ||||||
22 | Section 25. Study. | ||||||
23 | (a) Before July 1, 2022, and on a
biennial basis | ||||||
24 | thereafter, the Department, with the assistance
of: |
| |||||||
| |||||||
1 | (1) the Center for Minority Health Services; | ||||||
2 | (2) health care providers that treat individuals with | ||||||
3 | sickle cell
disease; | ||||||
4 | (3) individuals diagnosed with sickle cell disease; | ||||||
5 | (4) representatives of community-based organizations | ||||||
6 | that
serve individuals with sickle cell disease; and | ||||||
7 | (5) data collected via newborn screening for sickle | ||||||
8 | cell disease;
| ||||||
9 | shall perform a study to determine the prevalence, impact, and
| ||||||
10 | needs of individuals with sickle cell disease and the sickle | ||||||
11 | cell trait in
Illinois.
| ||||||
12 | (b) The study must include the following: | ||||||
13 | (1) The prevalence, by geographic location, of | ||||||
14 | individuals
diagnosed with sickle cell disease in | ||||||
15 | Illinois. | ||||||
16 | (2) The prevalence, by geographic location, of | ||||||
17 | individuals
diagnosed as sickle cell trait carriers in | ||||||
18 | Illinois. | ||||||
19 | (3) The availability and affordability of screening | ||||||
20 | services in
Illinois for the sickle cell trait.
| ||||||
21 | (4) The location and capacity of the following for the
| ||||||
22 | treatment of sickle cell disease and sickle cell trait | ||||||
23 | carriers:
| ||||||
24 | (A) Treatment centers. | ||||||
25 | (B) Clinics. | ||||||
26 | (C) Community-based social service organizations. |
| |||||||
| |||||||
1 | (D) Medical specialists.
| ||||||
2 | (5) The unmet medical, psychological, and social needs
| ||||||
3 | encountered by individuals in Illinois with sickle cell | ||||||
4 | disease. | ||||||
5 | (6) The underserved areas of Illinois for the | ||||||
6 | treatment of
sickle cell disease.
| ||||||
7 | (7) Recommendations for actions to address any | ||||||
8 | shortcomings
in the State identified under this Section. | ||||||
9 | (c) The Department shall submit a report on the study | ||||||
10 | performed
under this Section to the General Assembly.
| ||||||
11 | Section 30. Implementation subject to appropriation. | ||||||
12 | Implementation of this Act is subject to appropriation.
| ||||||
13 | Section 90. The State Finance Act is amended by adding | ||||||
14 | Section 5.935 as follows:
| ||||||
15 | (30 ILCS 105/5.935 new) | ||||||
16 | Sec. 5.935. The Sickle Cell Chronic Disease Fund.
|